Drug interactions
Canagliflozin + Lonapegsomatropin
Severity: Moderate
Canagliflozin and Lonapegsomatropin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Growth hormone products such as lonapegsomatropin can reduce insulin sensitivity, particularly at higher doses. In patients with diabetes this may raise blood glucose and blunt the effect of canagliflozin.
What this interaction means in plain words
Canagliflozin and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Canagliflozin belongs to Endocrine; Lonapegsomatropin belongs to Endocrine.
Why it happens
Pharmacodynamic antagonism: growth hormone induces insulin resistance and opposes the glucose-lowering action of antidiabetic agents.
What to do
Monitor blood glucose closely when starting or adjusting lonapegsomatropin in patients taking canagliflozin. Adjust antihyperglycemic doses as needed.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Canagliflozin and Lonapegsomatropin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Canagliflozin
Other interactions of Lonapegsomatropin
Frequently asked questions
Can I take Canagliflozin with Lonapegsomatropin?
MediHelp rates the interaction as moderate. Canagliflozin and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Growth hormone products such as lonapegsomatropin can reduce insulin sensitivity, particularly at higher doses. In patients with diabetes this may raise blood glucose and blunt the effect of canagliflozin.
How serious is the interaction between Canagliflozin and Lonapegsomatropin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely when starting or adjusting lonapegsomatropin in patients taking canagliflozin. Adjust antihyperglycemic doses as needed.
What other medicines interact with Canagliflozin?
MediHelp also lists interactions of Canagliflozin with, for example, Aliskiren, Amiloride, Amlodipine-benazepril. The full list is on the Canagliflozin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
